Abiomed (NSDQ:ABMD) today announced that its Impella technology won reimbursement coding and payment from healthcare regulators in the Netherlands.
The Danvers, Mass.-based medical device company called the win a "significant milestone" for its flagship Impella device, which the company calls the "world’s smallest heart pump."